Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-09-17

FDA Approved: ASMANEX — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for ASMANEX (mometasone furoate) from Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASMANEX (MOMETASONE FUROATE)

Snippet

SUPPL AP for ASMANEX (MOMETASONE FUROATE)